title: Sulfonylurea use during entire pregnancy in diabetes because of KCNJ11 mutation: a report of two cases.
authors.forename: Zsolt
authors.initials: Z
authors.lastname: Gaal
authors.forename: Tomasz
authors.initials: T
authors.lastname: Klupa
authors.forename: Irene
authors.initials: I
authors.lastname: Kantor
authors.forename: Wojciech
authors.initials: W
authors.lastname: Mlynarski
authors.forename: Laszlo
authors.initials: L
authors.lastname: Albert
authors.forename: Justyna
authors.initials: J
authors.lastname: Tolloczko
authors.forename: Istvan
authors.initials: I
authors.lastname: Balogh
authors.forename: Krzysztof
authors.initials: K
authors.lastname: Czajkowski
authors.forename: Maciej T
authors.initials: MT
authors.lastname: Malecki
mesh_terms: D000293:Adolescent; D000328:Adult; D001786:Blood Glucose / Q000187:drug effects / Q000378:metabolism; D003922:Diabetes Mellitus, Type 1 / Q000097:blood / Q000188:drug therapy* / Q000235:genetics; D005260:Female; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D009154:Mutation; D024661:Potassium Channels, Inwardly Rectifying / Q000097:blood / Q000235:genetics*; D011247:Pregnancy; D013453:Sulfonylurea Compounds / Q000627:therapeutic use*; D000099161:Kcnj11 Channel
chemical_list: D001786:Blood Glucose; D007004:Hypoglycemic Agents; D024661:Potassium Channels, Inwardly Rectifying; D013453:Sulfonylurea Compounds; D000099161:Kcnj11 Channel